Has George Jennings, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,884 in general payments to George Jennings, MD across 64 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean George Jennings, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about George Jennings, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

George Jennings, MD

Plastic and Reconstructive Surgery · Muscle Shoals, ALNPI 1518184035

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.5% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by AbbVie at 42.1% of the total. Reporting peaked in 2019 at $912 and has fallen 74.9% since, to $229 in 2025.

$2,884in general payments, 2019–2025

Across 64 payments — averaging $45.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Mentor Worldwide LLC$590
Elutia, Inc.$329
Integra Lifesciences Corporation$239
Sientra, Inc.$154
Kerecis Limited$134
plus $223 from 6 others

$59,000in research payments, 2019–2025

Across 7 payments — averaging $8428.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Elutia, Inc.$59K

What the payments were for

Food & beverage$2,75596%
Education$1294%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie(2 entities)	22	$1,214
Mentor Worldwide LLC	19	$590
Elutia, Inc.	2	$329
Integra Lifesciences Corporation	2	$239
Sientra, Inc.	6	$154
Kerecis Limited	4	$134
Revance Therapeutics, Inc.	1	$75
Galderma Laboratories, L.p.	3	$48
Merz North America, Inc.	2	$34
Solventum Corporation	1	$29
Smith+Nephew	1	$19
TELA Bio, Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INTEGRA$346
ALLODERM$316
NATRELLE$248
ECM Patch,Pouch$200
OMNIGRAFT$173
SURGIMEND$173
INTEGRA DERMAL REGENERATION TEMPLATE$173
SimpliDerm$129
ARTOURA Breast Tissue Expander$104
MemoryGel Breast Implants$104

How this compares

$2,884 in reported general payments places this provider in the 65th percentile of 35 plastic and reconstructive surgery providers in Alabama.

See all plastic and reconstructive surgery providers in Alabama →

Medicare billing

Part B allowed, 2024

$60,393

Medicare patients

109

Services billed

757

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	87	$474
Ondansetron Hcl	79	$456
Cephalexin	25	$106

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Muscle Shoals

Robert BollingTuscaloosa$71K
Brad DenneyBirmingham$21K
Tony WeaverHuntsville$13K
Michael BeckensteinBirmingham$10K
Jeffery WaldingDothan$10K
Robert OliverBirmingham$7K
Paul SauerBirmingham$6K
Michael BentleyMontgomery$5K
John RobertsonMontgomery$5K
Jonathan AntonettiBirmingham$4K

See the full list for Alabama →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →